Literature DB >> 18272293

Pronociceptive response elicited by TRPA1 receptor activation in mice.

E L Andrade1, A P Luiz, J Ferreira, J B Calixto.   

Abstract

Ankyrin-repeat transient receptor potential 1 (TRPA1) is a member of the transient receptor potential (TRP) channel family and it is found in sensory neurons. In the present study, we found that TRPA1 receptor activation with allyl isothiocyanate or cinnamaldehyde caused dose-dependent spontaneous nociception when injected into the mouse hind paw. Very similar results were obtained when stimulating transient receptor potential vanilloid 1 (TRPV1) receptors with capsaicin. Pretreatment with the TRP receptor antagonist Ruthenium Red (1 nmol/paw) inhibited capsaicin-(0.1 nmol/paw) and allyl isothiocyanate-(1 nmol/paw) induced nociceptive responses. However, the nonselective TRPV1 receptor antagonist capsazepine (1 nmol/paw) and the selective TRPV1 receptor antagonist SB 366791 (1 nmol/paw) only attenuated capsaicin-induced nociception. In contrast, the intrathecal treatment with TRPA1 antisense oligodeoxynucleotide (2.5 nmol/site) and the degeneration of the subset of primary afferent fibers sensitive to capsaicin significantly reduced allyl isothiocyanate-induced nociception. Consequently to TRPA1 antisense oligodeoxynucleotide treatment there was a marked decrease of the expression of TRPA1 receptor in both sciatic nervous and spinal cord segments. Moreover, capsaicin and allyl isothiocyanate-induced nociception were not significantly changed by chemical sympathectomy produced by guanethidine. The previous degranulation of mast cells by compound 48/80 and treatment with antagonist H(1) receptor antagonist pyrilamine (400 microg/paw) both significantly inhibited the capsaicin- and allyl isothiocyanate-induced nociception. The selective NK(1) receptor antagonist N(2)-[(4R)-4-hydroxy-1-(1-methyl-1H-indol-3-yl) carbony-1-L-prolyl]-N-methyl-N-phenylmethyl-3-2-(2-naphtyl)-L-alaninamide (10 nmol/paw) reduced either capsaicin- or allyl isothiocyanate-induced nociception. Collectively, the present findings demonstrate that the TRPA1 agonist allyl isothiocyanate produces a consistent nociceptive response when injected into the mouse paw, an effect that seems to be mediated via activation of TRPA1 receptor and dependent on the capsaicin-sensitive fibers, release of histamine by mast cells and participation of tachykinins. Thus, the TRPA1 receptor has an apparently relevant role in nociceptive processes and the selective TRPA1 antagonist might possess a potential antinociceptive property.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272293     DOI: 10.1016/j.neuroscience.2007.12.039

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

1.  Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice.

Authors:  Kazumasa Okubo; Midori Matsumura; Yudai Kawaishi; Yuka Aoki; Maho Matsunami; Yasumasa Okawa; Fumiko Sekiguchi; Atsufumi Kawabata
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

2.  TRPA1 agonists delay gastric emptying in rats through serotonergic pathways.

Authors:  Hitoshi Doihara; Katsura Nozawa; Eri Kawabata-Shoda; Ryosuke Kojima; Toshihide Yokoyama; Hiroyuki Ito
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-07-24       Impact factor: 3.000

3.  TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats.

Authors:  Steve McGaraughty; Katharine L Chu; Richard J Perner; Stan Didomenico; Michael E Kort; Philip R Kym
Journal:  Mol Pain       Date:  2010-03-05       Impact factor: 3.395

4.  Bimodal effects of cinnamaldehyde and camphor on mouse TRPA1.

Authors:  Yeranddy A Alpizar; Maarten Gees; Alicia Sanchez; Aurelia Apetrei; Thomas Voets; Bernd Nilius; Karel Talavera
Journal:  Pflugers Arch       Date:  2012-12-28       Impact factor: 3.657

5.  Behavioral evidence of thermal hyperalgesia and mechanical allodynia induced by intradermal cinnamaldehyde in rats.

Authors:  Merab G Tsagareli; Nana Tsiklauri; Karen L Zanotto; Mirela Iodi Carstens; Amanda H Klein; Carolyn M Sawyer; Gulnazi Gurtskaia; Elene Abzianidze; E Carstens
Journal:  Neurosci Lett       Date:  2010-02-26       Impact factor: 3.046

6.  TRPA1, substance P, histamine and 5-hydroxytryptamine interact in an interdependent way to induce nociception.

Authors:  Luana Fischer; Maria Isabel Lavoranti; Mariana de Oliveira Borges; Alana Farias Miksza; Natalia Fantin Sardi; Bruno Jacson Martynhak; Claudia H Tambeli; Carlos Amílcar Parada
Journal:  Inflamm Res       Date:  2016-11-30       Impact factor: 4.575

7.  Antinociceptive activity of Copaifera officinalis Jacq. L oil and kaurenoic acid in mice.

Authors:  Diéssica Padilha Dalenogare; Paula Ronsani Ferro; Samira Dal Toé De Prá; Flávia Karine Rigo; Caren Tatiane de David Antoniazzi; Amanda Spring de Almeida; Adriani Paganini Damiani; Giulia Strapazzon; Thanielly Thais de Oliveira Sardinha; Nathália Coral Galvani; Aline Augusti Boligon; Vanessa Moraes de Andrade; Evelyne da Silva Brum; Sara Marchesan Oliveira; Gabriela Trevisan
Journal:  Inflammopharmacology       Date:  2019-05-16       Impact factor: 4.473

8.  Excitation of cutaneous C nociceptors by intraplantar administration of anandamide.

Authors:  Carl Potenzieri; Thaddeus S Brink; Donald A Simone
Journal:  Brain Res       Date:  2009-03-10       Impact factor: 3.252

9.  Effects of neurokinin-1 receptor agonism and antagonism in the rostral ventromedial medulla of rats with acute or persistent inflammatory nociception.

Authors:  M V Hamity; S R White; D L Hammond
Journal:  Neuroscience       Date:  2009-11-03       Impact factor: 3.590

10.  Gallic acid functions as a TRPA1 antagonist with relevant antinociceptive and antiedematogenic effects in mice.

Authors:  Gabriela Trevisan; Mateus F Rossato; Raquel Tonello; Carin Hoffmeister; Jonatas Z Klafke; Fernanda Rosa; Kelly V Pinheiro; Francielle V Pinheiro; Aline A Boligon; Margareth L Athayde; Juliano Ferreira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-04-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.